Literature DB >> 15026033

The obligatory link: role of gap junctional communication in endothelium-dependent smooth muscle hyperpolarization.

Tudor M Griffith1, Andrew T Chaytor, David H Edwards.   

Abstract

Although an endothelium-derived hyperpolarizing factor (EDHF) has often been hypothesized to underpin vascular relaxations that are independent of nitric oxide (NO) and prostanoids, bioassay techniques have failed to confirm the existence of a freely transferable EDHF in a consistent fashion. Indeed, observations that inhibitors of direct cell-cell coupling such as connexin-mimetic peptides (e.g. Gap 26 and 27) and glycyrrhetinic acid derivatives attenuate "EDHF-type" smooth muscle hyperpolarizations and relaxations suggest that an electrotonic spread of endothelial hyperpolarization via myoendothelial and homocellular smooth muscle gap junctions plays an obligatory role in such responses. The endothelial hyperpolarization that initiates relaxation results from the opening of K(Ca) channels and is sustained by capacitative Ca(2+) entry triggered by the depletion of intracellular Ca(2+) stores in the endoplasmic reticulum. EDHF-type relaxations are also associated with a prostanoid-independent synthesis of cAMP that increases the conductance of gap junction channels and enhances the transmission of endothelial hyperpolarization through the vascular wall in a permissive fashion. This review will discuss the roles of these interacting signalling pathways in the mediation of the EDHF phenomenon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026033     DOI: 10.1016/j.phrs.2003.11.014

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  25 in total

1.  Perturbation of chemical coupling by an endothelial Cx40 mutant attenuates endothelium-dependent vasodilation by KCa channels and elevates blood pressure in mice.

Authors:  Daniel J Chaston; Rebecca E Haddock; Lauren Howitt; Susan K Morton; Russell D Brown; Klaus I Matthaei; Caryl E Hill
Journal:  Pflugers Arch       Date:  2014-11-05       Impact factor: 3.657

Review 2.  Connexins and the kidney.

Authors:  Fiona Hanner; Charlotte Mehlin Sorensen; Niels-Henrik Holstein-Rathlou; János Peti-Peterdi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-17       Impact factor: 3.619

3.  Role of the endothelium on arterial vasomotion.

Authors:  Michèle Koenigsberger; Roger Sauser; Jean-Louis Bény; Jean-Jacques Meister
Journal:  Biophys J       Date:  2005-03-25       Impact factor: 4.033

4.  Endothelium-derived hyperpolarizing factor and diabetes.

Authors:  Xue Gao; Luis A Martinez-Lemus; Cuihua Zhang
Journal:  World J Cardiol       Date:  2011-01-26

Review 5.  Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Authors:  Michel Félétou
Journal:  Br J Pharmacol       Date:  2009-01-29       Impact factor: 8.739

Review 6.  Functional roles of connexins and pannexins in the kidney.

Authors:  Ahmed B Abed; Panagiotis Kavvadas; Christos E Chadjichristos
Journal:  Cell Mol Life Sci       Date:  2015-06-17       Impact factor: 9.261

7.  Altered gap junctional communication and renal haemodynamics in Zucker fatty rat model of type 2 diabetes.

Authors:  T Takenaka; T Inoue; H Okada; Y Ohno; T Miyazaki; D J Chaston; C E Hill; H Suzuki
Journal:  Diabetologia       Date:  2011-05-15       Impact factor: 10.122

Review 8.  Human endothelial dysfunction: EDRFs.

Authors:  Andreas J Flammer; Thomas F Lüscher
Journal:  Pflugers Arch       Date:  2010-04-12       Impact factor: 3.657

Review 9.  Biological role of connexin intercellular channels and hemichannels.

Authors:  Rekha Kar; Nidhi Batra; Manuel A Riquelme; Jean X Jiang
Journal:  Arch Biochem Biophys       Date:  2012-03-17       Impact factor: 4.013

Review 10.  Defining the factors that affect solute permeation of gap junction channels.

Authors:  Virginijus Valiunas; Ira S Cohen; Peter R Brink
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-07-06       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.